Related Experiment Video
Updated: May 13, 2026

Left Coronary Artery Ligation: A Surgical Murine Model of Myocardial Infarction
Published on: August 9, 2022
Unprotected left main coronary artery disease. Surgical therapy
J Cremer1, J Schöttler, A Haneya
1Department of Cardiovascular Surgery, Universitätsklinikum Schleswig-Holstein, Campus Kiel, Arnold-Heller-Strasse 3, Kiel, Germany. jcremer@kielheart.uni-kiel.de
Insights
Coronary artery bypass grafting (CABG) is the recommended treatment for unprotected left main coronary artery (ULMCA) disease, offering excellent long-term outcomes. Further research is needed to compare CABG with percutaneous coronary intervention in real-world scenarios.
Area of Science:
- Cardiology
- Cardiovascular Surgery
Background:
- Unprotected left main coronary artery (ULMCA) disease requires careful treatment consideration.
- Coronary artery bypass grafting (CABG) is currently the guideline-recommended first-line therapy for ULMCA disease.
- CABG demonstrates excellent long-term results irrespective of lesion complexity or comorbidities.
Purpose of the Study:
- To review the current evidence regarding treatment options for ULMCA disease.
- To highlight the need for robust clinical trials comparing revascularization strategies for ULMCA lesions.
Main Methods:
- Review of existing randomized controlled trials (RCTs) and guidelines.
- Analysis of comparative effectiveness of CABG versus percutaneous coronary intervention (PCI) for ULMCA disease.
Main Results:
- Existing RCTs on PCI for ULMCA are often underpowered.
- PCI may show comparable results to CABG in less complex ULMCA lesions.
- CABG remains the established treatment with superior long-term outcomes.
Conclusions:
- An interdisciplinary approach is crucial for managing ULMCA disease.
- Further large-scale, all-comers RCTs are essential to provide real-world data on ULMCA revascularization.
- Current guidelines support CABG as the primary treatment for ULMCA disease.
Abstract:
Coronary artery bypass grafting (CABG) has been established as a safe concept in the treatment of unprotected left main coronary artery (ULMCA) disease and is considered the first-line treatment in current interdisciplinary guidelines. Regardless of the complexity of the lesion and the concomitant diseases, CABG is associated with excellent long-term results. Randomized controlled trials investigating the role of percutaneous coronary intervention in the setting of ULMCA lesions are frequently underpowered and suggest that, when restricted to less complex lesions, percutaneous coronary intervention is associated with results comparable to surgery. Thus, there is an urgent need for further randomized controlled trials RCTs with all-comers design to supply precise data under real-life conditions representative of the left main stem anatomy. Until then, an interdisciplinary approach to patients with ULMCA lesions is mandatory in view of the existing guidelines.
Related Concept Videos
Mitral Stenosis III: Medical Management
Cardiac Catheterization III: Left Heart Catheterization
Cardiomyopathy V: Interprofessional Care
Coronary Artery Disease V: Interprofessional Care
Aneurysm III: Interprofessional Care
Aortic Regurgitation III: Medical Management
